Abbott–Exact Sciences, BioMarin–Amicus among deals cleared in Japan in Q1
MLex Summary: Abbott Laboratories’ proposed acquisition of cancer screening and diagnostics company Exact Sciences was among the mergers cleared by Japan’s competition regulator in the January–March period. The Japan Fair Trade...To view the full article, register now.
Already a subscriber? Click here to view full article